BlackRock Group’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$581K Sell
273,850
-58,359
-18% -$163K ﹤0.01% 2309
2016
Q3
$1.11M Buy
332,209
+15,840
+5% +$50.3K ﹤0.01% 1975
2016
Q2
$993K Buy
316,369
+169,089
+115% +$564K ﹤0.01% 1979
2016
Q1
$490K Sell
147,280
-102,823
-41% -$321K ﹤0.01% 2247
2015
Q4
$885K Sell
250,103
-127,686
-34% -$534K ﹤0.01% 1968
2015
Q3
$1.9M Buy
377,789
+31,059
+9% +$178K ﹤0.01% 1524
2015
Q2
$2.23M Buy
346,730
+31,993
+10% +$214K ﹤0.01% 1497
2015
Q1
$2.21M Buy
314,737
+50,970
+19% +$369K ﹤0.01% 1434
2014
Q4
$2.04M Sell
263,767
-43,683
-14% -$346K ﹤0.01% 1463
2014
Q3
$2.3M Buy
307,450
+6,948
+2% +$64.5K ﹤0.01% 1366
2014
Q2
$2.91M Buy
300,502
+79,391
+36% +$708K ﹤0.01% 1308
2014
Q1
$1.84M Buy
221,111
+19,349
+10% +$166K ﹤0.01% 1627
2013
Q4
$1.7M Sell
201,762
-19,884
-9% -$168K ﹤0.01% 1635
2013
Q3
$1.77M Buy
221,646
+20,091
+10% +$162K ﹤0.01% 1538
2013
Q2
$1.56M Buy
+201,555
New +$1.57M ﹤0.01% 1438

Other funds holding PDLI